Dr. Weinreich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
624 Columbus Ave
Thornwood, NY 10594Phone+1 914-372-6111Fax+1 914-247-0160
Education & Training
- University of MarylandResidency, Surgery, 1997 - 2001
- Boston University School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2010 - 2026
- NY State Medical License 2015 - 2026
- MD State Medical License 2001 - 2017
- VA State Medical License 2003 - 2004
Publications & Presentations
PubMed
- 585 citationsCOLLOIDAL GOLD: A NOVEL NANOPARTICLE VECTOR FOR TUMOR DIRECTED DRUG DELIVERYGiulio F. Paciotti, Lonnie D. Myer, David M. Weinreich, Dan V. Goia, Nicolae Pavel
Drug Delivery. 2004-05-01 - 180 citationsEfficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, pl...Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork
Journal of the American Academy of Dermatology. 2020-11-01 - 1142 citationsREGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton, Shazia Ali, Haitao Gao
The New England Journal of Medicine. 2021-01-21
Journal Articles
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19David Weinreich, MD, The New England Journal of Medicine
Abstracts/Posters
- Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)David M. Weinreich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple MyelomaDavid M. Weinreich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton AwardNovember 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: